Our study not only confirmed CHAF1A abnormally high expression in cancers especially in breast cancer, but also demonstrated a strong correlation between CHAF1A overexpression, breast cancer molecular subtype, prognosis and treatment response. This evidence concerns the gene CHAF1A and breast carcinoma.